Novo Nordisk A/S (NYSE:NVO) is one of the best cheap stocks under $50 to buy right now. Novo Nordisk A/S (NYSE:NVO) announced ...

FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya® (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”) today announced that the Company has made a strategic decision to cease funding its German subsidiaries, Aeterna ...

In this article, we will look at the 12 Best Undervalued Stocks to Invest In Right Now. On March 3, Katie Stockton, Fairlead ...

Investing.com -- Novo Nordisk announced late Friday that the US Food and Drug Administration has approved three new indications for once-weekly Sogroya (somapacitan-beco) injection 5 mg, 10 mg, or 15 ...

COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) ("COSCIENS" or the "Company") today announced that the Company has made a strategic decision to ...

The approval gives Ascendis a window of opportunity to eat into BioMarin's market share, as the latter works on its own ...

Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.

Hair fall that won’t stop. Periods that arrive late, or not at all. Skin that suddenly breaks out. Many women blame stress, age, or “just hormones.” But doctors say one small mineral may quietly sit ...

STOCKHOLM, SWEDEN / ACCESS Newswire / March 2, 2026 / Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (NASDAQ Stockholm:EGTX), today announced the launch of two updated educational websites ...

Protein supports nearly every body process, not just muscle growth. Long-term deficiency can harm immunity, bone density, and energy levels.